Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Agro Albert — Vallon Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Agro Albert

Agro Albert

Chief Medical Officer at Vallon Pharmaceuticals, Inc. · on record since Apr 25, 2023

Insider trading activity of Agro Albert

Transactions on record: 1; since Apr 24, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 24, 2023

Figures computed from official regulatory filings — methodology.

Companies where Agro Albert has traded

Vallon Pharmaceuticals, Inc.1 tx · Apr 24, 2023

Track record of Agro Albert

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Agro Albert

Co-insiders of Agro Albert

Ammer RichardVallon Pharmaceuticals, Inc.
Arcturus Therapeutics Holdings Inc.Vallon Pharmaceuticals, Inc.
Baker David CharlesVallon Pharmaceuticals, Inc.
Chaturvedi VipinVallon Pharmaceuticals, Inc.
Chhabra MeenuVallon Pharmaceuticals, Inc.
Hertz Walter MarcVallon Pharmaceuticals, Inc.
Kelly Leanne M.Vallon Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Levi OfirVallon Pharmaceuticals, Inc.

Payne Joseph EVallon Pharmaceuticals, Inc.

Rongen RoelofVallon Pharmaceuticals, Inc.

SALMON Pharma GmbHVallon Pharmaceuticals, Inc.

SIMPSON CAMILLA VVallon Pharmaceuticals, Inc.

Szekeres David LeslieVallon Pharmaceuticals, Inc.

Thorell MarellaVallon Pharmaceuticals, Inc.

Toren PennyVallon Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Vallon Pharmaceuticals, Inc.	Apr 24, 2023	Award	172,189	—	—	SEC